secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stimcell Energetics Inc. (STME)
CIK:        0001493712
Form:       8-K
Filed at:   2022-04-27T23:59:59+00:00
Accession:  0001393905-22-000125
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cell MedX appoints Dwayne Yaretz as CEO; former CEO McEnulty remains director
-----------------------------------------------------------------------------

- Dwayne Yaretz appointed CEO and to the board on April 25, 2022, replacing Mr. McEnulty as CEO.
- Mr. McEnulty resigned as CEO but continues to serve as a director of Cell MedX.
- Yaretz has experience in medical imaging devices and corporate restructuring.
- No compensation arrangements for Yaretz as CEO or director have been disclosed.
- Yaretz aims to advance eBalance Systems Health Canada approvals and seek FDA 510K clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493712/000139390522000125/0001393905-22-000125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493712/000139390522000125/cmxc-20220425.htm
  HTML page:      https://secwatch.observer/filing/0001393905-22-000125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer